Reproducibility of HRV as a Biomarker for Transcutaneous Auricular Vagus Nerve Stimulation

Poster No:

27 

Submission Type:

Abstract Submission 

Authors:

Xue-Zhen XIAO1, Meng Yang2, Yao Xue3, Gan Huang4

Institutions:

1Zhuhai Fudan Innovation Institute, Zhuhai, China, 2Shenzhen University, Shenzhen, China, 3Zhejiang University Huzhou Institute, Huzhou, China, 4Shenzhen University, Shenzhen,China

First Author:

Xue-Zhen XIAO  
Zhuhai Fudan Innovation Institute
Zhuhai, China

Co-Author(s):

Meng Yang  
Shenzhen University
Shenzhen, China
Yao Xue  
Zhejiang University Huzhou Institute
Huzhou, China
Gan Huang  
Shenzhen University
Shenzhen,China

Introduction:

Transcutaneous auricular vagus nerve stimulation (taVNS) is a non-invasive treatment modality that delivers electrical stimulation to the auricular branch of the vagus nerve. It has shown promising effects in improving conditions such as sleep disorders and depression. Compared to implantable vagus nerve stimulation, taVNS avoids the risks associated with surgery and presents a cost-effective alternative. A key research focus in taVNS is identifying reliable and stable biomarkers that reflect effective vagus nerve modulation. Heart rate variability (HRV) has been suggested as a potential biomarker, yet its reproducibility remains underexplored.This study aims to investigate the reproducibility of HRV as a reliable biomarker for effective vagus nerve modulation through taVNS.

Methods:

Forty-two healthy university students participated in two repeated experiments one week apart, with half randomly assigned to the true stimulation group (electrical stimulation of the auricular concha) and half to the sham stimulation group (electrical stimulation of the earlobe). The experiment controlled for factors such as order, gender, stimulation type, and current parameters. Each session included a 10-minute resting baseline (no stimulation), a 10-minute stimulation period, and a 5-minute recovery phase (no stimulation). During the 25 minutes, participants watched a neutral video related to natural scenery while heart rate variability (HRV) was recorded via ECG. Stimulation parameters were: frequency 25 Hz, pulse width 300 µs, intensity from 0 to 6 mA, adjustable in 60 levels (0.1 mA per level) based on participant tolerance and comfort. Time-domain and frequency-domain HRV signals were extracted for calculating the intraclass correlation coefficient (ICC) as a measure of reproducibility for HRV as a taVNS biomarker.
Supporting Image: Figure-1118.jpg
   ·The positions of stimulation electrodes and ECG recording electrodes
 

Results:

During active stimulation, HRV (47.44 ms, measured by the RMSSD index) was significantly higher than during the resting period (43.86 ms) (t = 5.10, p < .001). The ICC for HRV between true and sham stimulation conditions was 0.75 for single measures and 0.86 for average measures, indicating strong consistency in HRV across different days for each participant. A similar pattern was observed for the high-frequency index of the R-R intervals, which reflects parasympathetic activity. However, the ICC for the HRV difference between the stimulation and baseline periods (ICC = 0.01) or between the stimulation and resting periods (ICC = 0.25) was significantly lower than the ICC for HRV measured at each individual stage.

Conclusions:

taVNS can significantly enhance parasympathetic excitability. Both time-domain and frequency-domain HRV measures can serve as biomarkers for taVNS. While HRV measures show high reproducibility across individuals, the reproducibility of HRV changes induced by taVNS modulation is relatively low. Further data exploration or the establishment of better control groups is needed for more in-depth investigation.

Brain Stimulation:

Non-invasive Electrical/tDCS/tACS/tRNS 1
Non-Invasive Stimulation Methods Other 2

Keywords:

ELECTROPHYSIOLOGY
Experimental Design
NORMAL HUMAN
Other - transcutaneous auricular vagus nerve stimulation

1|2Indicates the priority used for review

Abstract Information

By submitting your proposal, you grant permission for the Organization for Human Brain Mapping (OHBM) to distribute your work in any format, including video, audio print and electronic text through OHBM OnDemand, social media channels, the OHBM website, or other electronic publications and media.

I accept

The Open Science Special Interest Group (OSSIG) is introducing a reproducibility challenge for OHBM 2025. This new initiative aims to enhance the reproducibility of scientific results and foster collaborations between labs. Teams will consist of a “source” party and a “reproducing” party, and will be evaluated on the success of their replication, the openness of the source work, and additional deliverables. Click here for more information. Propose your OHBM abstract(s) as source work for future OHBM meetings by selecting one of the following options:

I am submitting this abstract as an original work to be reproduced. I am available to be the “source party” in an upcoming team and consent to have this work listed on the OSSIG website. I agree to be contacted by OSSIG regarding the challenge and may share data used in this abstract with another team.

Please indicate below if your study was a "resting state" or "task-activation” study.

Task-activation

Healthy subjects only or patients (note that patient studies may also involve healthy subjects):

Healthy subjects

Was this research conducted in the United States?

No

Were any human subjects research approved by the relevant Institutional Review Board or ethics panel? NOTE: Any human subjects studies without IRB approval will be automatically rejected.

Yes

Were any animal research approved by the relevant IACUC or other animal research panel? NOTE: Any animal studies without IACUC approval will be automatically rejected.

Not applicable

Please indicate which methods were used in your research:

Other, Please specify  -   transcutaneous auricular vagus nerve stimulation

Provide references using APA citation style.

Borges, U., Laborde, S., & Raab, M. (2019). Influence of transcutaneous vagus nerve stimulation on cardiac vagal activity: not different from sham stimulation and no effect of stimulation intensity. PloS one, 14(10), e0223848.
Bretherton, B., Atkinson, L., Murray, A., Clancy, J., Deuchars, S., & Deuchars, J. (2019). Effects of transcutaneous vagus nerve stimulation in individuals aged 55 years or above: potential benefits of daily stimulation. Aging (albany NY), 11(14), 4836.
Carandina, A., Rodrigues, G. D., Di Francesco, P., Filtz, A., Bellocchi, C., Furlan, L., ... & Tobaldini, E. (2021). Effects of transcutaneous auricular vagus nerve stimulation on cardiovascular autonomic control in health and disease. Autonomic Neuroscience, 236, 102893.
Forte, G., Favieri, F., Leemhuis, E., De Martino, M. L., Giannini, A. M., De Gennaro, L., ... & Pazzaglia, M. (2022). Ear your heart: transcutaneous auricular vagus nerve stimulation on heart rate variability in healthy young participants. PeerJ, 10, e14447.
Wolf, V., Kühnel, A., Teckentrup, V., Koenig, J., & Kroemer, N. B. (2021). Does transcutaneous auricular vagus nerve stimulation affect vagally mediated heart rate variability? A living and interactive Bayesian meta‐analysis. Psychophysiology, 58(11), e13933.

UNESCO Institute of Statistics and World Bank Waiver Form

I attest that I currently live, work, or study in a country on the UNESCO Institute of Statistics and World Bank List of Low and Middle Income Countries list provided.

No